Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2015 1
2016 1
2017 1
2018 1
2019 4
2020 2
2021 4
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors.
Prasongtanakij S, Preedagasamzin S, Jittorntrum B, Anurathapan U, Puavilai T, Niparuck P, Chantrathammachart P, Piyajaroenkij T, Uaesoontrachoon K, Uchibori R, Ozawa K, Ohmine K, Hongeng S. Prasongtanakij S, et al. Among authors: puavilai t. Eur J Haematol. 2024 Feb;112(2):248-256. doi: 10.1111/ejh.14007. Epub 2023 May 24. Eur J Haematol. 2024. PMID: 37222081
Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG.
Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C. Kungwankiattichai S, et al. Among authors: puavilai t. Hematology. 2023 Dec;28(1):2191462. doi: 10.1080/16078454.2023.2191462. Hematology. 2023. PMID: 36951362
Treatment outcome and prognostic factors in PCNSL.
Niparuck P, Boonsakan P, Sutthippingkiat T, Pukiat S, Chantrathammachart P, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Atichartakarn V. Niparuck P, et al. Among authors: puavilai t. Diagn Pathol. 2019 Jun 13;14(1):56. doi: 10.1186/s13000-019-0833-1. Diagn Pathol. 2019. PMID: 31189479 Free PMC article.
Targeting UCHL1 Induces Cell Cycle Arrest in High-Risk Multiple Myeloma with t(4;14).
Kamseng P, Siriboonpiputtana T, Puavilai T, Chuncharunee S, Paisooksantivatana K, Chareonsirisuthigul T, Junking M, Chiraphapphaiboon W, Yenchitsomanus PT, Rerkamnuaychoke B. Kamseng P, et al. Among authors: puavilai t. Pathol Oncol Res. 2021 Mar 31;27:606567. doi: 10.3389/pore.2021.606567. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257568 Free PMC article.
Treatment Outcomes and Clinical Relevance in Patients with Double Expressor DLBCL.
Rungwittayatiwat S, Boonsakan P, Chantrathammachart P, Puavilai T, Pukiat S, Phusanti S, Boonyawat K, Wacharapornin P, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Niparuck P. Rungwittayatiwat S, et al. Among authors: puavilai t. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021063. doi: 10.4084/MJHID.2021.063. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804437 Free PMC article.
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Tantiworawit A, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: puavilai t. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1075-e1083. doi: 10.1016/j.clml.2022.08.010. Epub 2022 Aug 23. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36117042
External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival.
Warnnissorn N, Kanitsap N, Niparuck P, Boonsakan P, Kulalert P, Limvorapitak W, Bhoopat L, Saengboon S, Chantrathammachart P, Puavilai T, Chuncharunee S. Warnnissorn N, et al. Among authors: puavilai t. Hematology. 2022 Dec;27(1):1237-1245. doi: 10.1080/16078454.2022.2147916. Hematology. 2022. PMID: 36413354
Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Rattarittamrong E, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Chanswangphuwana C, et al. Among authors: puavilai t. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e915-e921. doi: 10.1016/j.clml.2022.06.005. Epub 2022 Jun 12. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35792033
23 results